C-terminal brain (B-type) natriuretic peptide (BNP)-32 is a widely used clinical biomarker for the diagnosis, prognosis, and treatment of heart failure (HF). The 32-aa peptide is synthesized primarily ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering.
Point-of-care testing (POCT) is destined to play a much greater role in chronic disease diagnosis and management. Advanced POCT systems are being developed to deliver less costly and more acute ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する